LatestArticle

Complexica Pty Ltd, a leading provider of Artificial Intelligence software for optimising sales and marketing decisions, announced today that it has won a tender at Pfizer Australia for the deployment of its What-if Simulator & Optimiser, powered by Complexica’s award-winning Artificial Intelligence platform, Larry, the Digital Analyst®.

“After evaluating a number of software companies in the marketplace that possess advanced prediction and optimisation capabilities, we have ultimately selected Complexica as our vendor of choice.” said Andrew Endicott, Brand Manager for Pfizer Australia. “We have found that answering complex “what-if” questions is a challenging and time-consuming endeavour, and we believe that Complexica’s What-if Simulator & Optimiser can provide Pfizer Australia with a platform for scenario analysis that will improve our decision-making in the future. We look forward to working with Complexica to address some of the analytical and “what-if” challenges facing our business and operating environment.”

Pfizer Australia is part of Pfizer, Inc., which is the world's largest research-based pharmaceutical company, employing more than 96,000 people globally and turning over in excess of $52 billion annually. The company's key areas of focus are immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Since being founded in 1849, the company has been committed to applying science and its global resources to improve health and well-being at every stage of life. For more information about Pfizer, please visit: www.pfizer.com

Pfizer Australia is rolling out artificial intelligence-based digital analyst tools from Complexica in a bid to improve the pharmaceutical company’s data-driven sales and marketing decision making.

Based on its digital analyst engine, dubbed Larry, Complexica’s What-if Simulator allows Pfizer to test and optimise a range of scenarios based on internal and external data sets. In a statement, the company said it plans to use the software to simulate the impact of sales and marketing strategies, investigate assumptions and hypothesis difficult to test in the real world, and compare the outcome of various what-if scenarios in order to understand what’s contributing to business results.

Pfizer said the software will also help to understand deterministic and non-deterministic factors presented in its business operations, as well as see how variables within different questions impact one another. Pfizer brand manager, Andrew Endicott, said the group evaluated a number of predictive and optimisation offering before opting for Complexica.

ADELAIDE, SOUTH AUSTRALIA, 20 December 2016 – Complexica Pty Ltd, a leading provider of Artificial Intelligence software, announced today that it has signed a contract with Boehringer Ingelheim for the deployment of its What-if Simulator, powered by Larry, the Digital Analyst®.

“Like most innovative multi-national companies, Boehringer Ingelheim operates in a dynamic environment that has many moving parts,” said Jon Simpson, Head of Sales for Boehringer Ingelheim Australia and New Zealand. “Conducting timely and accurate data analysis is often a challenging and time-consuming endeavour, which requires significant human expertise. Complexica’s What-if Simulator, powered by Larry, the Digital Analyst, is ideally suited for the analytical challenges within our business and operating environment.”